--A mix-up at a U.S. factory will delay distribution of the Johnson & Johnson Covid-19 vaccine, the New York Times reported.
--The NYT said that workers at the Baltimore plant had accidentally conflated the vaccine's ingredients weeks ago and ruined about 15 million doses of Johnson & Johnson's vaccine.
--The plant is run by Emergent BioSolutions, a manufacturing partner to Johnson & Johnson and AstraZeneca PLC, the NYT said.
--Johnson & Johnson vaccine doses currently being delivered and used nationwide were produced in the Netherlands and are not affected, the NYT reported, adding that all further shipments of the Johnson & Johnson vaccine were supposed to have come from the Baltimore plant and are now in question while the quality control issues are sorted out.
In after-hours trading, Johnson & Johnson shares were down 0.33% at $163.81, while Emergent Solutions' stock was down 4.85% at $88.40.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.